DNMT3B and urinary bladder carcinoma: Bisulfite genomic sequencing (BSP) analysis showed that the methylation ratio of the miR-34a promoter was lower in the low-DNMT3B-expression bladder cancer tissues compared to that in the high-DNMT3B-expression tissues (Figure 2C).